Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct;15(10):577-92.
doi: 10.1038/nrc4000.

MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road

Affiliations
Review

MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road

Christopher J Caunt et al. Nat Rev Cancer. 2015 Oct.

Abstract

The role of the ERK signalling pathway in cancer is thought to be most prominent in tumours in which mutations in the receptor tyrosine kinases RAS, BRAF, CRAF, MEK1 or MEK2 drive growth factor-independent ERK1 and ERK2 activation and thence inappropriate cell proliferation and survival. New drugs that inhibit RAF or MEK1 and MEK2 have recently been approved or are currently undergoing late-stage clinical evaluation. In this Review, we consider the ERK pathway, focusing particularly on the role of MEK1 and MEK2, the 'gatekeepers' of ERK1/2 activity. We discuss their validation as drug targets, the merits of targeting MEK1 and MEK2 versus BRAF and the mechanisms of action of different inhibitors of MEK1 and MEK2. We also consider how some of the systems-level properties (intrapathway regulatory loops and wider signalling network connections) of the ERK pathway present a challenge for the success of MEK1 and MEK2 inhibitors, discuss mechanisms of resistance to these inhibitors, and review their clinical progress.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 2015 Jan 1;372(1):30-9 - PubMed
    1. Nat Genet. 2013 Aug;45(8):927-32 - PubMed
    1. Genes Dev. 2003 Dec 15;17(24):3112-26 - PubMed
    1. Cancer Discov. 2014 May;4(5):538-45 - PubMed
    1. Bioorg Med Chem Lett. 2011 Mar 15;21(6):1795-801 - PubMed

MeSH terms

LinkOut - more resources

-